Diphenhydramine Hydrochloride Injection
Product Images NDC 51662-1219

6 FDA label images from Hf Acquisition Co. Llc, Dba Health First · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hydrochloride (NDC 51662-1219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of diphenhydramine hydrochloride, depicted as a molecular diagram showing aromatic rings, an ether linkage, and a dimethylamino group attached to the molecule.*
FDA Label Image

Rfid Label (51662 1219 1 Rfid Label)

Rfid Label (51662 1219 1 Rfid Label)
This is a close-up image of a label with barcode and alphanumeric codes, including a GS1 DataMatrix barcode. The label includes text instructing to see the manufacturer's insert and states distribution by HF Acquisition Co., LLC in Mukilteo, WA 98275. The label does not provide visible product name or strength, only packaging related data elements.*
FDA Label Image

Vial Label (1000200 0641 0376 21 Diphenhydramine Vial)

Vial Label (1000200 0641 0376 21 Diphenhydramine Vial)
Label for Diphenhydramine Hydrochloride Injection, USP 50 mg/mL, a human prescription drug for intramuscular or intravenous use. The label indicates a 1 mL vial and highlights that it is high potency. It advises protection from light and is manufactured by West-Ward, under HF Acquisition Co. LLC, DBA Health First.*
FDA Label Image

Pouch Label (51662 1219 2)

Pouch Label (51662 1219 2)
DIPHENHYDRAMINE HYDROCHLORIDE injection label for 1mL vial with strength 50 mg/mL. The label includes NDC 51662-1219-2, Lot number HF1234TESTING, and expiration date 2023-09-19. It states the route of administration as intramuscular or slow intravenous use and storage instructions between 20-25°C (68-77°F). Distributed by HF Acquisition Co. LLC, DBA Health First, Mukilteo, WA 98275.*
FDA Label Image

Case Label (51662 1219 3)

Case Label (51662 1219 3)
DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP 50 mg/mL label for a 1 mL vial. The label indicates the NDC 51662-1219-9, lot number, and expiration date 2023-09-19. It is distributed by HF Acquisition Co. LLC, DBA Health First, Mukilteo, WA. The vial is intended for intramuscular or slow intravenous use and sold in a box of 25 vials.*
FDA Label Image

Rfid Label (51662 1219 3 Rfid)

Rfid Label (51662 1219 3 Rfid)
A close-up image of a white label on a pharmaceutical product containing Diphenhydramine Hydrochloride injection. The label displays batch and expiration information in black text, including barcode data. It notes distribution by HF Acquisitions Co., LLC in Mukilteo, WA, and indicates the presence of the manufacturer's insert inside the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.